Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 17:2020:1020843.
doi: 10.1155/2020/1020843. eCollection 2020.

Joint Detection of Serum IgM/IgG Antibody Is an Important Key to Clinical Diagnosis of SARS-CoV-2 Infection

Fang Hu  1 , Xiaoling Shang  1 , Meizhou Chen  1 , Changliang Zhang  1
Affiliations

Joint Detection of Serum IgM/IgG Antibody Is an Important Key to Clinical Diagnosis of SARS-CoV-2 Infection

Fang Hu et al. Can J Infect Dis Med Microbiol. .

Abstract

Background: This study was aimed to investigate the application of SARS-CoV-2 IgM and IgG antibodies in diagnosis of COVID-19 infection.

Method: This study enrolled a total of 178 patients at Huangshi Central Hospital from January to February 2020. Among them, 68 patients were SARS-CoV-2 infected, confirmed with nucleic acid test (NAT) and CT imaging. Nine patients were in the suspected group (NAT negative) with fever and other respiratory symptoms. 101 patients were in the control group with other diseases and negative to SARS-CoV-2 infection. After serum samples were collected, SARS-CoV-2 IgG and IgM antibodies were tested by chemiluminescence immunoassay (CLIA) for all patients.

Results: The specificity of serum IgM and IgG antibodies to SARS-CoV-2 was 99.01% (100/101) and 96.04% (97/101), respectively, and the sensitivity was 88.24% (60/68) and 97.06% (66/68), respectively. The combined detection rate of SARS-CoV-2 IgM and IgG antibodies was 98.53% (67/68).

Conclusion: Combined detection of serum SARS-CoV-2 IgM and IgG antibodies had better sensitivity compared with single IgM or IgG antibody testing, which can be used as an important diagnostic tool for SARS-CoV-2 infection and a screening tool of potential SARS-CoV-2 carriers in clinics, hospitals, and accredited scientific laboratories.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

References

    1. Hui D. S., Azhar E. I., Madani T. A., et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—the latest 2019 novel coronavirus outbreak in Wuhan, China. International Journal of Infectious Diseases. 2020;91:264–266. doi: 10.1016/j.ijid.2020.01.009. - DOI - PMC - PubMed
    1. Corman V. M., Landt O., Kaiser M., et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveillance. 2020;25(3) doi: 10.2807/1560-7917.ES.2020.25.3.2000045.2000045 - DOI - PMC - PubMed
    1. Li J., Ye G., Chen L., Wang J., Li Y. Analysis of false-negative results for 2019 novel coronavirus nucleic acid test and related countermeasures. Chinese Journal of Laboratory Medicine. 2020;43E006
    1. Jin Y., Wang M., Zuo Z., et al. Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019. International Journal of Infectious Diseases. 2020;94:49–52. doi: 10.1016/j.ijid.2020.03.065. - DOI - PMC - PubMed
    1. Qu J., Wu C., Li X., et al. Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clinical Infectious Diseases. 2020 doi: 10.1093/cid/ciaa489.ciaa489 - DOI - PMC - PubMed

LinkOut - more resources